Therapeutic insights into the treatment of Stress-induced heart failure: Interlukin-17 (IL-17) protects against stress-induced heart failure via up regulation of SNX13, 22/March/2015, 11.17 am

Anti-metastasis therapy: Tumor suppressor p53 homologue TAp73 and p63 suppress the expression of actin-regulatory proteins FHOD1 and PPM1F and inhibit migration and invasion of metastatic cancer cells via up regulation of their target gene, 21/March/2015, 23.11
March 21, 2015
Natural product-based therapy for cancer: Cirsilol (3′,4′,5-trihydroxy-6,7-dimethoxyflavone), a flavone isolated from Achillea fragrantissima, suppresses the expression of RNA polymerase III via down regulation of its target gene, 22/March/2015, 22.22
March 22, 2015
Show all

A recent study from the Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine, Shanghai 200120, China shows that “SNX13 reduction mediates heart failure through degradative sorting of apoptosis repressor with caspase recruitment domain.” This study was published in the 8 October issue of 2014 Online journal “Nature Communications” by Prof Chen YH, Li J, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Therapeutic insights into the treatment of Stress-induced heart failure: Interlukin-17 (IL-17) protects against stress-induced heart failure via up regulation of SNX13. 

Significance: This study suggests, for the first time, that IL-17, by decreasing the expression of its target genes, it may increase the expression of Sorting nexin-13 (SNX13).  Thereby, it may inhibit activation of apoptotic pathways, while activating survival pathways in cardiac cells. Thus, pharmacological formulations encompassing IL-17 activators may be used to treat myocardial disorders, including myocardial infarction.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Therapeutic insights into the treatment of Stress-induced heart failure: Interlukin-17 (IL-17) protects against stress-induced heart failure via up regulation of SNX13, 22/March/2015, 11.17 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.